State Ledger
Company profile

Neurogene Inc. CIK 1404644

Ticker
NGNE (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
New York, NY 10011
Fiscal year end
2025 (FY)
Market Data
Close
$24.43
Change
-$1.90
Change %
-7.20%
Volume
13,867

NGNE · trading date Oct 12, 2026 · previous close $26.32 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$0
Net income
-$90.35M
Total assets
$288.60M
Total liabilities
$23.72M
Stockholders' equity
$264.89M
Cash & equivalents
$103.85M
Operating income
-$103.33M
Operating cash flow
-$77.17M
Capital expenditures
$1.18M

Fiscal year 2025, via 10-K filed 2026-03-24. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$78.36M
Free cash flow margin
—
Liabilities / assets
8.2%
Equity / assets
91.8%
CapEx / revenue
—
Operating cash flow / net income
0.85×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $0 -$90.35M $288.60M $23.72M $264.89M
2024 $925.0K -$75.14M $335.73M $25.36M $310.38M
2023 $0 -$36.32M $222.57M $36.55M $186.02M
2022 — -$55.19M $109.27M $10.64M -$145.74M
2021 — -$60.69M $163.26M $20.40M -$91.88M
Company Details
SIC code
2834
Active filer
Yes
Most recent SEC filing
Form SCHEDULE 13G/A
2026-08-14
Financials filed via
Form 10-K
filed 2026-03-24

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
New York, NY 10011
535 W 24TH STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:43 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New York — Public Companies